Abstract
Background: The relationship between hyperhomocysteinemia and cardiovascular disease has not been totally elucidated.
Hypothesis: The study aimed to verify the association between hyperhomocysteinemia and endothelial dysfunction before and after modification of total homocysteine (tHcy) serum levels with vitamin supplementation in young male subjects devoid of any other cardiovascular risk factor.
Methods: Twenty hyperhomocysteinemic (tHcy gt; 15 μmol/1) male volunteers (≤ 40 years) and 20 age‐matched subjects with normal tHcy levels (tHcy < 13 μmol/1) were included. Exclusion criteria were smoking, hypertension, diabetes, vitamin ingestion, obesity, hypercholesterolemia, renal failure, and positive antiphospholipid antibodies. Serum tHcy, folate, vitamin B12 levels, activated protein C and S, protein C resistance, fibrinogen, prothrombin, thrombin, antithrombin III, and in vitro oxidation of low‐density lipoprotein (LDL) particles were measured. Noninvasive ultrasound measurements of endothelium‐dependent (EDD) and ‐independent dilatation (EID) of the brachial artery were performed. Each pair was then randomly assigned to receive a vitamin capsule (0.6 mg folic acid, 0.8 mg B12, and 2.0 mg B6) or an identical placebo during 8 weeks, in a double‐blind study design. After the treatment phase, blood samples and vascular reactivity were repeated.
Results: Nine pairs of volunteers received vitamins and 11 received placebo. Hyperhomocysteinemic subjects had lower baseline serum levels of vitamin B12. Serum folate levels, antithrombotic function, in vitro LDL oxidation, and EDD were similar in all groups. After the vitamin supplementation, serum folic acid levels increased significantly both in normo‐and hyperhomocysteinemic subjects, unlike vitamin B12, which increased only in the hyperhomocysteinemic individuals. Plasma tHcy decreased significantly in the supplemented groups. Treatment with vitamins was not associated with improvement in EDD or antithrombotic function.
Conclusions: Mild hyperhomocysteinemia is not associated with endothelial dysfunction in young male subjects with no additional cardiovascular risk factors, and reduction of tHcy by vitamin supplementation does not modify EDD in this age group. In this sample, tHcy was more related to vitamin B12 than to folic acid status.
Keywords: homocysteine, vitamin B12, folic acid, endothelial dysfunction
Full Text
The Full Text of this article is available as a PDF (45.4 KB).
References
- 1. Nygard O, Nordrehaug JE, Refsum H, Ueland PM, Farstad M, Vollset SE: Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 1997; 337: 230–236. [DOI] [PubMed] [Google Scholar]
- 2. Selhub J, Jacques PF, Bostom AG, D'Agostino R, Wilson P, Belanger AJ, O'Leary DH, Wolf PA, Schaefer EJ , Rosenberg I: Association between plasma homocysteine concentrations and extracranial carotid‐artery stenosis. N Engl J Med 1995; 332: 286–291. [DOI] [PubMed] [Google Scholar]
- 3. Bostom AG, Rosenberg IH, Silbershatz H, Jacques PF, Selhub J, D'Agostino RB, Wilson PW, Wolf PA: Nonfasting plasma total homocysteine levels and all‐cause and cardiovascular disease mortality in elderly Framingham men and women. Arch Intern Med 1999; 24: 1077–1080. [DOI] [PubMed] [Google Scholar]
- 4. Danesh J, Lewington S: Plasma homocysteine and coronary heart disease: Systematic review of published epidemiological studies. J Card Vasc Risk 1998; 5: 229–232. [PubMed] [Google Scholar]
- 5. Hankey GJ, Eikelboom JW: Homocysteine and vascular disease. Lancet 1999: 354: 407–413 [DOI] [PubMed] [Google Scholar]
- 6. Welch GN, Loscalzo J: Mechanisms of disease: Homocysteine atherothrombosis. N Engl J Med 1998; 338: 1042–1050. [DOI] [PubMed] [Google Scholar]
- 7. Jakubowski H: Protein homocysteinylation: Possible mechanism underlying pathological consequences of elevated homocysteine levels. FASEB J 1999; 13: 2277–2283. [PubMed] [Google Scholar]
- 8. Galasse SP, Selwyn AP, Ganz P: Atherosclerosis: Risk factors and the vascular endothelium. Am Heart J 1996; 131: 379–384. [DOI] [PubMed] [Google Scholar]
- 9. Celermajer DS, Sorensen KE, Bull C, Robinson J, Deanfield JE: Endothelium dependent dilatation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol 1994; 24: 1468–1474. [DOI] [PubMed] [Google Scholar]
- 10. Lentz SR, Sobey CG, Piegors DJ, Bhopatkar M, Faraci FM, Malinow MR: Vascular dysfunction in monkeys with diet induced hyperhomocysteinemia. J Clin Invest 1996; 98: 24–29. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Bellamy MF, McDowel IFW, Ramsey MW, Brownlee M, Bones C, Newcombe RG, Lewis MJ: Hyperhomocysteinemia after oral methionine load acutely impairs endothelial function in healthy adults. Circulation 1998; 98: 1848–1852. [DOI] [PubMed] [Google Scholar]
- 12. Nappo F, De Rosa N, Marfella R, De Lucia D, Ingrosso D, Perna AF, Farzati B, Giugliano D: Impairment of endothelial functions by acute hyperhomocysteinemia and reversal by antioxidant vitamins. J Am Med Assoc 1999; 281: 2113–2118. [DOI] [PubMed] [Google Scholar]
- 13. Vemeulen EGJ, Stehouver CDA, Twisk JWR, van den Berg M, de Jong SC, Mackaay AJC, van Campen CMC: Effect of homocysteine‐lowering treatment with folic acid plus vitamin B6 on progression of subclinical atherosclerosis: A randomized, placebo‐controlled trial. Lancet 2000; 355: 517–522. [DOI] [PubMed] [Google Scholar]
- 14. Esterbauer H, Striegl G, Puhl H, Rotheneder M: Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radic Res Commun 1989; 6: 67–75. [DOI] [PubMed] [Google Scholar]
- 15. Sorensen KE Celermajer DS, Spiegelhalter DJ: Non‐invasive measurement of human endothelium dependent arterial responses: Accuracy and reproducibility. Br Heart J 1995; 6: 67–75. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Jacques PF, Selhub J, Bostom AG, Wilson PW, Rosenberg IH: The effect of folic acid fortification on plasma folate and total homocysteine concentrations. N Engl J Med 1999; 340: 1449–1454. [DOI] [PubMed] [Google Scholar]
- 17. Robinson K, Arheart K, Refsum H, Brattström L, Boers G, Ueland P, Rubba P, Palma‐Reis R, Meleady R, Daly L, Witteman J, Graham I, for the European COMAC Group : Low circulating folate and vitamin B6 concentrations risk factor for stroke, peripheral vascular disease, and coronary artery disease. Circulation 1998; 97: 437–443. [DOI] [PubMed] [Google Scholar]
- 18. Bauman WA, Shaw S, Jayatilleke E, Spungen AM, Herbert V: Increased intake of calcium reverses vitamin B12 malabsorption induced by metformin. Diabetes Care 2000; 23: 1227–1231. [DOI] [PubMed] [Google Scholar]
- 19. Kaptan K, Beyan C, Ural AU, Cetin T, Avcu F, Gulsen M, Finci R, Yalcin A: Helicobacterpylori—is it a novel causative agent in vitamin B12 deficiency? Arch Intern Med 2000; 160: 1349–1353. [DOI] [PubMed] [Google Scholar]
- 20. Figueroa G, Acuña R, Troncoso M, Portell DP, Toledo MS, Valenzuela J: Helicobacter pylori infection in Chile. Clin Infect Dis 1997; 25: 96–102. [DOI] [PubMed] [Google Scholar]
- 21. Hanratty CG, McAuley DF, McGrath LT, Young IS, Johnston GD: Hyperhomocysteinaemia in young adults is not associated with impaired endothelial function. Clin Sci (Colch) 2001; 100: 67–72. [PubMed] [Google Scholar]
- 22. Celermajer DS, Sorenson KE, Ryalls M, Robinson J, Thomas Q, Leonard JV, Deanfild JE: Impaired endothelial function occurs in the systemic arteries of children with homozygous homocysteinuria but not in their heterozygous parents. J Am Coll Cardiol 1993; 22: 854–858. [DOI] [PubMed] [Google Scholar]
- 23. Hanratty CG, McGrath LT, McAuley DF, Young IS, Johnston GD: The effects of oral methionine and homocysteine on endothelial function. Heart 2001; 85: 326–330. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24. Usui M, Matsuoka H, Miyazaki H, Ueda S, Imaizumi T: Endothelial dysfunction by acute hyperhomocysteinemia: Restoration by folic acid. Clin Sci 1999; 96: 235–239. [PubMed] [Google Scholar]
- 25. Chao CL, Chien KL, Lee YT: Effect of short‐term vitamin (folic acid, vitamin B6 and B12) administration on endothelial dysfunction induced by post‐methionine load hyperhomocysteinemia. Am J Cardiol 1999; 84: 1359–1361. [DOI] [PubMed] [Google Scholar]
- 26. Woo KS, Chook P, Lolin YI, Sanderson JE, Metreweli C, Celer‐majer DS: Folic acid improves arterial endothelial function in adults with hyperhomocystinemia. J Am Coll Cardiol 1999; 34: 2002–2006. [DOI] [PubMed] [Google Scholar]
- 27. Chambers JC, Ueland PM, Obeid OA, Wrigley J, Refsum H, Kooner JS: Improved vascular endothelial function after oral B vitamins: An effect mediated through reduced concentrations of free plasma homocysteine. Circulation 2000; 102: 2479–2483. [DOI] [PubMed] [Google Scholar]
- 28. Thambyajah J, Landray MJ, McGlynn FJ, Jones HJ, Wheeler DC, Townend JN: Does folic acid decrease plasma homocysteine and improve endothelial function in patients with predialysis renal failure? Circulation 2000; 102: 871–875. [DOI] [PubMed] [Google Scholar]
- 29. Lentz SR, Piegors DJ, Malinow MR, Heistad DD: Supplementation of atherogenic diet with B vitamins does not prevent atherosclerosis or vascular dysfunction in monkeys. Circulation 2001; 1031: 1006–1011. [DOI] [PubMed] [Google Scholar]
- 30. Harman D: Free radical theory of aging. Mutation Res 1992; 275: 257–266. [DOI] [PubMed] [Google Scholar]
- 31. Freyburger G, Labrouche S, Sassoust G, Rouanet F, Javorschi S, Parrot F: Mild hyperhomocysteinemia and hemostatic factors in patients with arterial vascular diseases. Thromb Haemost 1997; 77: 466–171. [PubMed] [Google Scholar]
- 32. Lentz SR, Sadler JE: Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine. J Clin Invest 1991; 88: 1906–1914. [DOI] [PMC free article] [PubMed] [Google Scholar]